NOT KNOWN FACTS ABOUT RESEARCH CHEMICALS KOPEN NEDERLAND

Although the medical relevance of the aforementioned cardiovascular risk factor alterations by tirzepatide will probably be assessed inside the planned cardiovascular outcome study SURPASS-CVOT ( "style":"clinical-trial","attrs": "textual content":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-Evaluation ind